Abstract:The 70-kDa heat shock protein (HSP70) family of molecular chaperones represents one of the most ubiquitous classes of chaperones and is highly conserved in all organisms. Members of the HSP70 family control all aspects of cellular proteostasis such as nascent protein chain folding, protein import into organelles, recovering of proteins from aggregation, and assembly of multi-protein complexes. These chaperones augment organismal survival and longevity in the face of proteotoxic stress by enhancing cell viability and facilitating protein damage repair. Extracellular HSP70s have a number of cytoprotective and immunomodulatory functions, the latter either in the context of facilitating the cross-presentation of immunogenic peptides via major histocompatibility complex (MHC) antigens or in the context of acting as “chaperokines” or stimulators of innate immune responses. Studies have linked the expression of HSP70s to several types of carcinoma, with Hsp70 expression being associated with therapeutic resistance, metastasis, and poor clinical outcome. In malignantly transformed cells, HSP70s protect cells from the proteotoxic stress associated with abnormally rapid proliferation, suppress cellular senescence, and confer resistance to stress-induced apoptosis including protection against cytostatic drugs and radiation therapy. All of the cellular activities of HSP70s depend on their adenosine-5′-triphosphate (ATP)-regulated ability to interact with exposed hydrophobic surfaces of proteins. ATP hydrolysis and adenosine diphosphate (ADP)/ATP exchange are key events for substrate binding and Hsp70 release during folding of nascent polypeptides. Several proteins that bind to distinct subdomains of Hsp70 and consequently modulate the activity of the chaperone have been identified as HSP70 co-chaperones. This review focuses on the regulation, function, and relevance of the molecular Hsp70 chaperone machinery to disease and its potential as a therapeutic target.

Heat shock protein 110: A novel candidate for disease diagnosis and targeted therapy

Heat Shock Protein 90 in Neurodegenerative Diseases

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Heat-shock proteins: new keys to the development of cytoprotective therapies

Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone?

Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery

Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases

The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases

Hsp70 Protein Complexes as Drug Targets

Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

The human HSP70 family of chaperones: where do we stand?

With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage

Heat-shock protein 70: molecular supertool?

The known unknowns of the Hsp90 chaperone

The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease

The Hsp90 molecular chaperone: an open and shut case for treatment

Structure, Function, and Regulation of the Hsp90 Machinery

Membrane heat shock protein 70: a theranostic target for cancer therapy

Small heat-shock proteins: important players in regulating cellular proteostasis